| $129M | ||
| $100M | ||
| $50M | ||
| $9M | ||
| $8M | ||
| $4M |
Buys | $2,211,927 | 2 | 67 |
Sells | $35,210 | 1 | 33 |
| NOVO GUILLERMO | Chair of the Board and CEO | 1 | $2.01M | 0 | $0 | $2.01M |
| Assis Alessandra Faccin | SVP and GM, Life Sciences | 1 | $201,600 | 0 | $0 | $201,600 |
| BONI ERIC N | VP, Finance & Prinpl Acctg Off | 0 | $0 | 1 | $35,210 | $-35,210 |
Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. Ashland Inc. was founded in 1924 and is based in Wilmington, Delaware.
Over the last 12 months, insiders at Ashland Inc. have bought $2.21M and sold $35,210 worth of Ashland Inc. stock.
On average, over the past 5 years, insiders at Ashland Inc. have bought $28.51M and sold $9.79M worth of stock each year.
Highest buying activity among insiders over the last 12 months: NOVO GUILLERMO (Chair of the Board and CEO) — $2.01M. Assis Alessandra Faccin (SVP and GM, Life Sciences) — $201,600.
The last purchase of 3,150 shares for transaction amount of $201,600 was made by Assis Alessandra Faccin (SVP and GM, Life Sciences) on 2025‑01‑31.
| 2025-01-31 | NOVO GUILLERMO | Chair of the Board and CEO | 31,294 0.0668% | $64.24 | $2.01M | -17.43% | ||
| 2025-01-31 | Assis Alessandra Faccin | SVP and GM, Life Sciences | 3,150 0.0067% | $64.00 | $201,600 | -17.43% | ||
| 2024-12-05 | Sale | BONI ERIC N | VP, Finance & Prinpl Acctg Off | 451 0.001% | $78.07 | $35,210 | -30.11% | |
| 2024-11-19 | Sale | LAMPKIN ROBIN E. | SVP, Gen Counsel and Secrty. | 162 0.0003% | $75.54 | $12,237 | -29.27% | |
| 2024-11-15 | Sale | LAMPKIN ROBIN E. | SVP, Gen Counsel and Secrty. | 868 0.0018% | $77.90 | $67,617 | -29.71% | |
| 2024-09-04 | Sale | WILLIS J KEVIN | SVP and CFO | 5,487 0.0112% | $87.88 | $482,198 | -31.74% | |
| 2024-02-16 | Sale | LAMPKIN ROBIN E. | SVP, Gen Counsel and Secrty. | 844 0.0017% | $92.54 | $78,104 | -3.29% | |
| 2023-12-07 | Sale | BONI ERIC N | Principal Accounting Officer | 843 0.0016% | $82.38 | $69,446 | +8.84% | |
| 2023-09-05 | Sale | WILLIS J KEVIN | Sr.VP &Chief Financial Officer | 7,866 0.0155% | $86.54 | $680,724 | +7.00% | |
| 2022-09-01 | Sale | Sandler Ricky C | See Remarks | 224,156 0.415% | $100.20 | $22.46M | -0.46% | |
| 2022-09-01 | Sale | EMINENCE CAPITAL, LP | 224,156 0.415% | $100.20 | $22.46M | -0.46% | ||
| 2022-09-01 | Sandler Ricky C | See Remarks | 224,156 0.415% | $100.20 | $22.46M | -0.46% | ||
| 2022-09-01 | EMINENCE CAPITAL, LP | 224,156 0.415% | $100.20 | $22.46M | -0.46% | |||
| 2022-06-08 | Sale | BONI ERIC N | Principal Accounting Officer | 2,657 0.0049% | $109.50 | $290,942 | -5.29% | |
| 2022-06-07 | Sale | BONI ERIC N | Principal Accounting Officer | 2,657 0.0049% | $109.50 | $290,942 | -6.84% | |
| 2022-06-02 | Sale | WILLIS J KEVIN | Sr.VP &Chief Financial Officer | 4,235 0.0077% | $105.58 | $447,131 | -4.37% | |
| 2022-06-01 | Sale | WILLIS J KEVIN | Sr.VP &Chief Financial Officer | 2,374 0.0044% | $105.58 | $250,647 | -2.07% | |
| 2022-05-17 | Sandler Ricky C | See Remarks | 48,800 0.0901% | $101.27 | $4.94M | +2.28% | ||
| 2022-05-17 | EMINENCE CAPITAL, LP | 48,800 0.0901% | $101.27 | $4.94M | +2.28% | |||
| 2021-09-10 | Sale | WILLIS J KEVIN | Chief Financial Officer | 2,208 0.0039% | $94.30 | $208,214 | +8.89% |
| NOVO GUILLERMO | Chair of the Board and CEO | 31294 0.0685% | $1.82M | 2 | 0 | <0.0001% |
| BONI ERIC N | VP, Finance & Prinpl Acctg Off | 14182 0.031% | $826,385.14 | 0 | 6 | |
| Assis Alessandra Faccin | SVP and GM, Life Sciences | 3150 0.0069% | $183,550.50 | 1 | 0 | |
| EMINENCE CAPITAL, LP | 4083978 8.9335% | $237.97M | 2 | 1 | +0.91% | |
| Sandler Ricky C | See Remarks | 4083978 8.9335% | $237.97M | 2 | 2 | +0.91% |
| FERNANDEZ-MORENO LUIS M | Senior Vice President | 45990 0.1006% | $2.68M | 0 | 1 | |
| Ganz Peter | Senior Vice President | 41532 0.0908% | $2.42M | 0 | 6 | |
| WILLIS J KEVIN | SVP and CFO | 17052 0.0373% | $993,620.04 | 0 | 23 | |
| Schumann Anne T. | Senior Vice President | 13197 0.0289% | $768,989.19 | 0 | 4 | |
| HEITMAN WILLIAM J | Controller | 6303 0.0138% | $367,275.81 | 0 | 6 | |
| Silverman Keith C | Vice President | 3714 0.0081% | $216,414.78 | 0 | 5 | |
| LAMPKIN ROBIN E. | SVP, Gen Counsel and Secrty. | 3354 0.0073% | $195,437.58 | 0 | 3 | |
| KALYANA SWAMINATHAN ASHOK | Sr VP & Gen Mgr, Life Sciences | 100 0.0002% | $5,827.00 | 1 | 0 | +14.77% |
| MUSA OSAMA M | Sr. Vice President | 0 0% | $0 | 0 | 1 |
| Increased Positions | 160 | +36.28% | 4M | +9.16% |
| Decreased Positions | 196 | -44.44% | 6M | -13.33% |
| New Positions | 57 | New | 1M | New |
| Sold Out Positions | 45 | Sold Out | 1M | Sold Out |
| Total Postitions | 405 | -8.16% | 43M | -4.17% |
| Vanguard Group Inc | $243,948.00 | 10.03% | 4.61M | -39,691 | -0.85% | 2025-09-30 |
| Blackrock, Inc. | $226,026.00 | 9.29% | 4.27M | -269,369 | -5.93% | 2025-09-30 |
| Aqr Capital Management Llc | $172,263.00 | 7.08% | 3.26M | -198,248 | -5.74% | 2025-09-30 |
| Massachusetts Financial Services Co /Ma/ | $148,124.00 | 6.09% | 2.8M | -47,255 | -1.66% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $126,806.00 | 5.21% | 2.4M | -116,109 | -4.62% | 2025-09-30 |
| Omega Advisors Inc. | $89,930.00 | 3.7% | 1.7M | 0 | 0% | 2025-09-30 |
| State Street Corp | $81,004.00 | 3.33% | 1.53M | +4,145 | +0.27% | 2025-09-30 |
| Diamond Hill Capital Management Inc | $76,977.00 | 3.16% | 1.46M | -41,879 | -2.8% | 2025-09-30 |
| 1832 Asset Management L.P. | $72,574.00 | 2.98% | 1.37M | +146 | +0.01% | 2025-09-30 |
| American Century Companies Inc | $59,449.00 | 2.44% | 1.12M | +1M | +807.77% | 2025-09-30 |